Michael Laflamme
Corporate Officer/Principal en University of Washington .
Perfil
Michael Laflamme is the founder of BEAT BioTherapeutics Corp, which was founded in 2008.
He is currently an Associate Professor-Pathology at the University of Washington.
Cargos activos de Michael Laflamme
| Empresas | Cargo | Inicio |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Michael Laflamme.
| Empresas | Cargo | Fin |
|---|---|---|
BEAT BioTherapeutics Corp.
 BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
BEAT BioTherapeutics Corp.
BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Laflamme
